The Significance of cGMP and Dopamine Receptor on the Natriuretic and Hypotensive Activities of Synthetic Atrial Natriuretic Polypeptide in Essential Hypertension

Folia Endocrinologica Japonica
doi 10.1507/endocrine1927.66.2_83
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japan Endocrine Society

Related search

The Elusive Role of Atrial Natriuretic Peptide in Hypertension

Mayo Clinic Proceedings
Medicine
1995English

Significance of the Pulmonary Arterial Pressure on the Release of Atrial Natriuretic Peptide (Abstract) : SYMPOSIUM ON ATRIAL NATRIURETIC POLYPEPTIDE (ANP): Basic and Clinical Research : 51th Annual Scientific Session of the Japanese Circulation Society

Japanese Circulation Journal
1988English

Plasma Atrial Natriuretic Peptide Concentration and Platelet Atrial Natriuretic Peptide Binding Site Density in Ageing and Hypertension

Clinical Science
1991English

Determination of Plasma ^|^alpha; Human Atrial Natriuretic Polypeptide Using

Folia Endocrinologica Japonica
1989English

The Atrial Natriuretic Factor in Hypertension. State of the Art Lecture.

Hypertension
Internal Medicine
1988English

MEASUREMENT OF ATRIAL NATRIURETIC PEPTIDE (ANP), cGMP, ALDOSTERONE AND VASOPRESSIN LEVELS IN INFANTS

Pediatric Research
Child HealthPediatricsPerinatology
1988English

In Vivo Evidence That cGMP Is the Second Messenger for Atrial Natriuretic Factor.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1986English

A Monoclonal Antibody to Alpha-Human Atrial Natriuretic Polypeptide

Hypertension
Internal Medicine
1988English

Human Atrial Natriuretic Polypeptide and PGI2 Generation by Vascular Endothelial Cells.

Blood & Vessel
1987English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy